Publicación:
Cost-effectiveness analysis of 10- and 13-valent pneumococcal conjugate vaccines in Peru

dc.contributor.author Mezones-Holguin E. es_PE
dc.contributor.author Canelo-Aybar C. es_PE
dc.contributor.author Clark A.D. es_PE
dc.contributor.author Janusz C.B. es_PE
dc.contributor.author Jaúregui B. es_PE
dc.contributor.author Escobedo-Palza S. es_PE
dc.contributor.author Hernandez A.V. es_PE
dc.contributor.author Vega-Porras D. es_PE
dc.contributor.author González M. es_PE
dc.contributor.author Fiestas F. es_PE
dc.contributor.author Toledo W. es_PE
dc.contributor.author Michel F. es_PE
dc.contributor.author Suárez V.J. es_PE
dc.date.accessioned 2024-05-30T23:13:38Z
dc.date.available 2024-05-30T23:13:38Z
dc.date.issued 2015
dc.description This study was made possible through the financial support of the Instituto Nacional de Salud (National Institute of Health, Lima, Peru) and the PROVAC Initiative of the Pan American Health Organization (Washington, DC, USA). This study was presented at 9th International Symposium of Pneumococci and Pneumococcal Diseases, Hyderabad, India, March 2014, and supported by the National Council of Science, Technology and Technological Innovation of Peru (CONCYTEC) and International Clinical Epidemiology Network (INCLEN Trust).
dc.description.sponsorship Consejo Nacional de Ciencia, Tecnología e Innovación Tecnológica - Concytec
dc.identifier.doi https://doi.org/10.1016/j.vaccine.2014.12.039
dc.identifier.scopus 2-s2.0-85047695497
dc.identifier.uri https://hdl.handle.net/20.500.12390/655
dc.language.iso eng
dc.publisher Elsevier Ltd
dc.relation.ispartof Vaccine
dc.rights info:eu-repo/semantics/openAccess
dc.subject Pneumococcus vaccine
dc.subject 10-valent pneumococcal conjugate vaccine es_PE
dc.subject 13-valent pneumococcal vaccine es_PE
dc.subject acute otitis media es_PE
dc.title Cost-effectiveness analysis of 10- and 13-valent pneumococcal conjugate vaccines in Peru
dc.type info:eu-repo/semantics/article
dspace.entity.type Publication
Archivos